Sunshine Guojian Pharmaceutical (Shanghai) Balance Sheet Health
Financial Health criteria checks 5/6
Sunshine Guojian Pharmaceutical (Shanghai) has a total shareholder equity of CN¥5.0B and total debt of CN¥50.0M, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are CN¥5.9B and CN¥872.3M respectively. Sunshine Guojian Pharmaceutical (Shanghai)'s EBIT is CN¥246.2M making its interest coverage ratio -4.1. It has cash and short-term investments of CN¥1.3B.
Key information
1.0%
Debt to equity ratio
CN¥50.03m
Debt
| Interest coverage ratio | -4.1x |
| Cash | CN¥1.32b |
| Equity | CN¥5.05b |
| Total liabilities | CN¥872.27m |
| Total assets | CN¥5.92b |
Recent financial health updates
Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Has A Rock Solid Balance Sheet
Nov 19
Is Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) A Risky Investment?
Jun 20Recent updates
Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Has A Rock Solid Balance Sheet
Nov 19Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Oct 29There's Reason For Concern Over Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) Massive 30% Price Jump
Oct 01What Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) P/E Is Not Telling You
Jul 25Is Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) A Risky Investment?
Jun 20If EPS Growth Is Important To You, Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Presents An Opportunity
May 24We Think That There Are Issues Underlying Sunshine Guojian Pharmaceutical (Shanghai)'s (SHSE:688336) Earnings
Mar 31Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHSE:688336) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 04Financial Position Analysis
Short Term Liabilities: 688336's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥760.6M).
Long Term Liabilities: 688336's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥111.7M).
Debt to Equity History and Analysis
Debt Level: 688336 has more cash than its total debt.
Reducing Debt: 688336's debt to equity ratio has increased from 0% to 1% over the past 5 years.
Debt Coverage: 688336's debt is well covered by operating cash flow (612.1%).
Interest Coverage: 688336 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 16:33 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wen Dai | Huatai Research |
| Yuan Yuan Sun | Industrial Securities Co. Ltd. |
| Ban Wang | Minsheng Securities Co. |